GABAergic Modulation in Diabetic Encephalopathy-Related Depression

E-ISSN： 1873-4286|21|34|4980-4988

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.34, 2015-10, pp. : 4980-4988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lactulose drives down costs of encephalopathy-related MVAs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Metronidazole: Worsening of encephalopathy-related movement disorders: case report

Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite

Physiological Targets for the Treatment of Diabetic Encephalopathy

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 78-86

Bentham Science Publishers

Access to resources Recommend Favorite

Glial Modulation of GABAergic and Glutamat ergic Neurotransmission

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-05 ,pp. : 929-934

Bentham Science Publishers

Access to resources Recommend Favorite

GABAergic and Glutamatergic Modulation in Binge Eating: Therapeutic Approach

Current Pharmaceutical Design, Vol. 17, Iss. 14, 2011-05 ,pp. : 1396-1409

Bentham Science Publishers

Access to resources Recommend Favorite